ECONOMYNEXT – Singapore has approved a 60 second breathalyzer test for Coronavirus which was developed by Breathonix, a medical start-up linked to the National University of Singapore.
“Breathonix is now working with the Singapore Ministry of Health (MOH) to run a deployment trial of their technology at Tuas Checkpoint where incoming travellers will undergo screening…” the National University of Singapore and Breathonix said in a statement.
Travellers are now checked through a rapid antigen tests.
Breathonix was founded by three NUS graduates Jia Zhunan, Du Fang and Wayne Wee Shi Jie, along with Jia’s PhD advisor, Professor T. Venky Venkatesan, NUS and Breathonix said in a statement.
“Our breath test is non-invasive,” Jia said. “Users only need to breathe out normally into the disposable mouthpiece provided, so there will not be any discomfort.
“Cross-contamination is unlikely as the disposable mouthpiece has a one-way valve and a saliva trap to prevent inhalation or saliva from entering the machine.”
The exhaled breath is collected and fed into a cutting mass spectrometer for measurement. A software algorithm analyses the VOCs biomarkers, to generate results in less than a minute.
Positive patients will go through a Polymerase Chain Reaction (PCR) COVID-19 swab test for confirmation.
Clinical trials were carried out from June June 2020 to April 2021 at the National Centre for Infectious Diseases and Changi Airport.
A third trial was carried out in Dubai, in collaboration with the Dubai Health Authority and the Mohammed Bin Rashid University of Medicine and Health Sciences, the statement said.